Clinical impact of <sup>99m</sup>Tc-MAA SPECT/CT-based personalized predictive dosimetry in selective internal radiotherapy: a real-life single-center experience in unresectable HCC patients.

Eur J Hybrid Imaging · 2023 · PMC10326228 · PMID 37414964

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

Nevertheless, this difference was not persistent for disease control rate at 3 months with 86.7% response in group B versus 61.1% in group A ( p = 0.15), nor at 6 months with 77.8% for group B versus 33.3% for group A, despite a clear trend for a better efficacy of personalized treatment.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.